Literature DB >> 16849516

Reduced peripheral and mucosal Tropheryma whipplei-specific Th1 response in patients with Whipple's disease.

Verena Moos1, Désirée Kunkel, Thomas Marth, Gerhard E Feurle, Bernard LaScola, Ralf Ignatius, Martin Zeitz, Thomas Schneider.   

Abstract

Whipple's disease is a rare infectious disorder caused by Tropheryma whipplei. Major symptoms are arthropathy, weight loss, and diarrhea, but the CNS and other organs may be affected, too. The incidence of Whipple's disease is very low despite the ubiquitous presence of T. whipplei in the environment. Therefore, it has been suggested that host factors indicated by immune deficiencies are responsible for the development of Whipple's disease. However, T. whipplei-specific T cell responses could not be studied until now, because cultivation of the bacteria was established only recently. Thus, the availability of T. whipplei Twist-Marseille(T) has enabled the first analysis of T. whipplei-specific reactivity of CD4(+) T cells. A robust T. whipplei-specific CD4(+) Th1 reactivity and activation (expression of CD154) was detected in peripheral and duodenal lymphocytes of all healthy (16 young, 27 age-matched, 11 triathletes) and disease controls (17 patients with tuberculosis) tested. However, 32 Whipple's disease patients showed reduced or absent T. whipplei-specific Th1 responses, whereas their capacity to react to other common Ags like tetanus toxoid, tuberculin, actinomycetes, Giardia lamblia, or CMV was not reduced compared with controls. Hence, we conclude that an insufficient T. whipplei-specific Th1 response may be responsible for an impaired immunological clearance of T. whipplei in Whipple's disease patients and may contribute to the fatal natural course of the disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16849516     DOI: 10.4049/jimmunol.177.3.2015

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  29 in total

1.  High frequency of Tropheryma whipplei in culture-negative endocarditis.

Authors:  Walter Geissdörfer; Verena Moos; Annette Moter; Christoph Loddenkemper; Andreas Jansen; René Tandler; Andreas J Morguet; Florence Fenollar; Didier Raoult; Christian Bogdan; Thomas Schneider
Journal:  J Clin Microbiol       Date:  2011-11-30       Impact factor: 5.948

2.  A rare intestinal infection with systemic effects.

Authors:  Randy S Longman; Roger K Moreira; Dan R Littman; Peter H R Green; Amrita Sethi
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-01

3.  [New therapeutic approaches to special diseases of the small intestine].

Authors:  M Schumann; K Herrlinger; M Zeitz; E F Stange
Journal:  Internist (Berl)       Date:  2010-06       Impact factor: 0.743

4.  Neurological presentation of Whipple's disease after long-term antibiotic treatment: a case report.

Authors:  Felix Gundling; Henning Wittenburg; Andrea Tannapfel; Joachim Mossner
Journal:  J Med Case Rep       Date:  2008-06-03

5.  Tropheryma whipplei in the environment: survey of sewage plant influxes and sewage plant workers.

Authors:  Maximilian Schöniger-Hekele; Dagmar Petermann; Beate Weber; Christian Müller
Journal:  Appl Environ Microbiol       Date:  2007-02-02       Impact factor: 4.792

6.  -295 T-to-C promoter region IL-16 gene polymorphism is associated with Whipple's disease.

Authors:  F Biagi; A Schiepatti; C Badulli; I Sbarsi; L Trotta; G E Feurle; C Müller; V Moos; T Schneider; T Marth; M De Amici; M Martinetti; G R Corazza
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-07-08       Impact factor: 3.267

Review 7.  Whipple's disease.

Authors:  Federico Biagi; Lucia Trotta; Gino R Corazza
Journal:  Intern Emerg Med       Date:  2012-10       Impact factor: 3.397

8.  Cytokine genetic profile in Whipple's disease.

Authors:  F Biagi; C Badulli; G E Feurle; C Müller; V Moos; T Schneider; T Marth; J Mytilineos; F Garlaschelli; A Marchese; L Trotta; P I Bianchi; M Di Stefano; A L Cremaschi; A De Silvestri; L Salvaneschi; M Martinetti; G R Corazza
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-07-31       Impact factor: 3.267

9.  Epidemiology of Whipple's Disease in the USA Between 2012 and 2017: A Population-Based National Study.

Authors:  Jamie Ann Elchert; Emad Mansoor; Mohannad Abou-Saleh; Gregory S Cooper
Journal:  Dig Dis Sci       Date:  2018-11-28       Impact factor: 3.199

10.  IL-16 promotes T. whipplei replication by inhibiting phagosome conversion and modulating macrophage activation.

Authors:  Eric Ghigo; Abdoulaye Oury Barry; Lionel Pretat; Khatoun Al Moussawi; Benoît Desnues; Christian Capo; Hardy Kornfeld; Jean-Louis Mege
Journal:  PLoS One       Date:  2010-10-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.